Advisory: Alert wrongly tagged to Gold Rain Enterprises withdrawn
An alert on Japan's Astellas Pharma 4503.T announcing its five-year growth strategy was inadvertently tagged to Taiwan-based electrical machinery manufacturer Gold Rain Enterprises Corp 4503.TWO, an unrelated company, and has been withdrawn. There will be no substitute. STORY_NUMBER: nTUA9JXD0B STORY_DATE: 26/05/2026 STORY_TIME: 06:45:00 GMT
Recent news on Astellas Pharma
See all newsBrief: Immuneering To Collaborate With Astellas On Clinical Studies Of Investigational CLDN18.2 Programs In Combination With Atebimetinib For Pancreatic Cancer Patients
Health Rounds: New blood test finds early risk for ovarian cancer
Health Rounds: New blood test finds early risk for ovarian cancer
Refile: Astellas employee imprisoned in China to be released in December, Japanese media report
Table: Astellas Pharma -6-MTH group results (IFRS)